Skip to content

CVE-2026-86060

MikroTik RouterOS Improper Neutralization of Argument Delimiters in a Command Vulnerability

  • Actively exploited
  • Critical · 9.2 of 10
Exploited since
10 Sep 2026
added to the CISA list
Chance of attacks
6.4%
in the next 30 days (FIRST EPSS)
Fix deadline
13 Sep 2026
for US federal agencies
Published
5 Sep 2026
in the NVD

What this means

MikroTik RouterOS contains an improper neutralization of argument delimiters in a command vulnerability which allows an attacker to change the trusted RouterOS policy mask, leading to privilege escalation.

CISA

RouterOS contains an argument-handling flaw in the SSH login path involving usernames that begin with a prohibited character, allowing for the trusted RouterOS policy mask to be changed, leading to privilege escalation. Exploitation requires an unauthenticated SSH session to reach the RouterOS login helper.This issue was fixed in versions: 6.49.21 (Long-term), 7.23.4 (Long-term) and 7.24.2 (Stable)

NIST National Vulnerability Database

What to do

Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.

CISA's required action. If you use the product, install the vendor's update as soon as possible.

Affected

  • Mikrotik RouterOS

Official sources

Data from the NIST National Vulnerability Database, the CISA Known Exploited Vulnerabilities list, FIRST EPSS and ENISA, checked 18 Nov 2026. CVSS vector CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:.

By using this site, you agree to the Privacy Policy.